Vlandonix Protocol
Dosing & Research
Last Updated: September 4, 2026
Thymus support research, Immune aging models, T-cell and thymic function, Recovery protocols
Half-Life
Not Well Characterized
Administration
Oral
Frequency
1-2 times daily with food
How It Works
- Thymus support research
- Immune aging models
- T-cell and thymic function
- Recovery protocols
Dosing Structure
Dose
20–40 mg
Frequency
1-2 times daily with food
Notes
Typically Administered As Defined Courses (10–20 Days) Repeated 1–2x Per Year, Rather Than Continuous Daily Dosing. Based On Khavinson Institute And Associated Russian Clinical Research.
Example Protocols
Dose: 20–40 mg
Frequency: 1-2 times daily with food
Duration: 10-30 days
Off Period: Not listed
Find Research Grade Vlandonix
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
•
Typically administered as defined courses (10–20 days) repeated 1–2x per year, rather than continuous daily dosing.
•
Based on Khavinson Institute and associated Russian clinical research.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.